Clinical Trials
3 trialsNCT06922539 2025-12-15
ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
SciTech Development, Inc.
Phase 1 Recruiting
NCT01553071 2022-03-31
Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed Malignancies
South Plains Oncology Consortium
Phase 1 Terminated
NCT02163356 2022-03-31
SPOC2013-001
South Plains Oncology Consortium
Phase 1 Terminated